< Back to latest news & events

Event

LSPN North America Spring 2023

March 2023

HGF are gold sponsors of the LSPN North America Spring 2023 in Boston on the 3 – 4th of May.

Brought to you by Life Sciences Intellectual Property Review, this in-person event presents an unrivalled gathering of in-house patent counsel pharmaceutical and biotechnology companies.

HGF Patent Director Dr Lauris Kemp is speaking alongside Daniel Rudoy, Shareholder at Wolf Greenfield, on ‘The WHAT, WHY and HOW of protecting the IP in your Bioinformatics and AI inventions’.

HGF Partner and Patent Attorney Dr Claire Irvine is hosting a CRISPR roundtable on Day 2, of the event, on ‘Navigating the Current CRISPR Patent and Licensing Landscape’. HGF Patent Director Marie Walsh is hosting a roundtable session on Day 2, of the event, on ‘Current Challenges and Sharing Solutions in Precision Medicine Protection’.

Attendees

Latest updates

Quinas Technology Wins WIPO Global Award for Innovation in ICT

Our client, Quinas Technology, has been named the winner of the WIPO Global Award 2025 in the ICT Startup category. Quinas is a spin-out from Lancaster University. We have worked …

Read article

IP Ingredients: Summer Case Law Review 2025

As the British summer swings once again between sunburn and showers, it’s a great time to take stock of what the first half of the year has delivered by way …

Read article

Celebrating exam success at HGF!

We are once again delighted to share that our colleagues have achieved success in their recent exams! Their dedication, perseverance, and commitment to professional development have paid off, and we …

Read article

Is the Supreme Court denial in Thatcher’s case a fatal blow against lookalikes?

The dispute between Thatcher’s Cider Company and Aldi Stores Limited has been long running and has sparked legal controversy along the way. On 4th June 2025 the Supreme denied Aldi …

Read article

HGF ranked among Europe’s top patent firms in IP STARS Patent Rankings 2025

HGF has once again made a bold mark in the latest Managing IP Stars 2025 firm rankings, with top-tier recognition across multiple jurisdictions for our patent expertise. This year’s results …

Read article

The Enlarged Board of Appeal has today issued its decision in seminal case G1/24

G1/24, described as one of the most important cases in decades, relates to how claims of patents are to be interpreted by the Boards of Appeal and, by extension, all …

Read article

UPC’s Hamburg Local Division provides guidance on the extent to which a patent may be used as its own “lexicon”

Agfa NV v Gucci & Anors. [UPC_CFI_278/2023] – Hamburg Local Division of the UPC (Klepsch, Schilling, Sarlin) – 30 April 2025 While we await a decision on G1/24 from the …

Read article

MevoCem Nominated for the Earthshot Prize by CIPA

We’re delighted to share that our client, Material Evolution, has been nominated by the Chartered Institute of Patent Attorneys (CIPA) for the globally renowned Earthshot Prize, in recognition of their …

Read article